Details of the Drug Formulations

General Information of Drug (ID: DMWMPD4)

• Drug Name: Vorinostat Drug Info
• Synonyms: NHNPODA; SAHA; SHH; Zolinza; Merck brand of Vorinostat; OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE; SAHA cpd; Suberanilohydroxamic acid; Suberoylanilide hydroxamic acid; Vorinostat MSD; Vorinostat [USAN]; M344; MK0683; SKI390; WIN64652; MK-0683; SAHA, Suberoylanilide hydroxamic acid; SW-064652; Zolinza (TN); Vorinostat (JAN/USAN); N1-hydroxy-N8-phenyloctanediamide; Zolinza, MK-0683, SAHA; N'-hydroxy-N-phenyloctanediamide; N-Hydroxy-N'-phenyl octanediamide; N-Hyrdroxy-N'-phenyloctanediamide; N-hydroxy-N'-phenyloctanediamide; N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide; Vorinostat (HDAC inhibitor)

Indication

Disease Entry	ICD 11	Status	REF
Adult acute monocytic leukemia		Approved	[1]
Cutaneous T-cell lymphoma	2B01	Approved	[2]
Ovarian neoplasm		Approved	[1]
Plasma cell myeloma	2A83.1	Approved	[1]
Primary cutaneous T-cell lymphoma		Approved	[1]
Adult glioblastoma		Investigative	[1]

• Therapeutic Class: Anticancer Agents
• Cross-matching ID:
  PubChem CID: 5311
  ChEBI ID: CHEBI:45716
  CAS Number: 149647-78-9
  TTD ID: D0E7PQ
  VARIDT ID: DR00769
  INTEDE ID: DR1710
  ACDINA ID: D00734

Full List of Drug Formulations Containing This Drug

Vorinostat 100 mg capsule

Company	Formulation ID	FDA Description
Merck Sharp & Dohme	F22499	Sodium lauryl sulfate; Magnesium stearate; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Gelatin

References

• [1] Vorinostat FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6852).